CSR...MACD crossover. Closed above the 8EMA yesterday.41EMA is 1.69 so a close at 1.69 augers well for next weekFirst target would to close the gap at 1.78
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
